Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takaoki Kasahara is active.

Publication


Featured researches published by Takaoki Kasahara.


Nature Genetics | 2003

Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder.

Chihiro Kakiuchi; Kazuya Iwamoto; Mizuho Ishiwata; Miki Bundo; Takaoki Kasahara; Ichiro Kusumi; Takahiro Tsujita; Yuji Okazaki; Shinichiro Nanko; Hiroshi Kunugi; Tsukasa Sasaki; Tadafumi Kato

The pathophysiology of bipolar disorder is still unclear, although family, twin and linkage studies implicate genetic factors. Here we identified XBP1, a pivotal gene in the endoplasmic reticulum (ER) stress response, as contributing to the genetic risk factor for bipolar disorder. Using DNA microarray analysis of lymphoblastoid cells derived from two pairs of twins discordant with respect to the illness, we found downregulated expression of genes related to ER stress response in both affected twins. A polymorphism (−116C→G) in the promoter region of XBP1, affecting the putative binding site of XBP1, was significantly more common in Japanese patients (odds ratio = 4.6) and overtransmitted to affected offspring in trio samples of the NIMH Bipolar Disorder Genetics Initiative. XBP1-dependent transcription activity of the −116G allele was lower than that of the −116C allele, and in the cells with the G allele, induction of XBP1 expression after ER stress was markedly reduced. Valproate, one of three mood stabilizers, rescued the impaired response by inducing ATF6, the gene upstream of XBP1. These results indicate that the −116C→G polymorphism in XBP1 causes an impairment of its positive feedback system and increases the risk of bipolar disorder.


Nature | 2003

Nutritional biochemistry: A new redox-cofactor vitamin for mammals

Takaoki Kasahara; Tadafumi Kato

Nicotinamides and flavins are essential cofactors in enzyme-catalysed reduction–oxidation (redox) reactions and are classified as vitamins because they must be supplied in the diet. Another redox cofactor, pyrroloquinoline quinone (PQQ), was first discovered in bacteria and is also likely to be important in mammals, but the biochemical pathways in which it participates are unknown. Here we identify a PQQ-dependent dehydrogenase enzyme that is crucial for the degradation of the amino acid lysine in mice. PQQ is acting as a mammalian redox cofactor in this reaction, and therefore qualifies as a newcomer to the B group of vitamins.


Molecular Psychiatry | 2006

Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes

Takaoki Kasahara; Mie Kubota; Taeko Miyauchi; Yukihiro Noda; Akihiro Mouri; Toshitaka Nabeshima; Tadafumi Kato

There is no established genetic model of bipolar disorder or major depression, which hampers research of these mood disorders. Although mood disorders are multifactorial diseases, they are sometimes manifested by one of pleiotropic effects of a single major gene defect. We focused on chronic progressive external ophthalmoplegia (CPEO), patients with which sometimes have comorbid mood disorders. Chronic progressive external ophthalmoplegia is a mitochondrial disease, which is accompanied by accumulation of mitochondrial DNA (mtDNA) deletions caused by mutations in nuclear-encoded genes such as POLG (mtDNA polymerase). We generated transgenic mice, in which mutant POLG was expressed in a neuron-specific manner. The mice showed forebrain-specific defects of mtDNA and had altered monoaminergic functions in the brain. The mutant mice exhibited characteristic behavioral phenotypes, a distorted day–night rhythm and a robust periodic activity pattern associated with estrous cycle. These abnormal behaviors resembling mood disorder were worsened by tricyclic antidepressant treatment and improved by lithium, a mood stabilizer. We also observed antidepressant-induced mania-like behavior and long-lasting irregularity of activity in some mutant animals. Our data suggest that accumulation of mtDNA defects in brain caused mood disorder-like mental symptoms with similar treatment responses to bipolar disorder. These findings are compatible with mitochondrial dysfunction hypothesis of bipolar disorder.


Proceedings of the National Academy of Sciences of the United States of America | 2010

Genetic variation of melatonin productivity in laboratory mice under domestication.

Takaoki Kasahara; Kuniya Abe; Kazuyuki Mekada; Atsushi Yoshiki; Tadafumi Kato

Melatonin is a pineal hormone produced at night; however, many strains of laboratory mice are deficient in melatonin. Strangely enough, the gene encoding HIOMT enzyme (also known as ASMT) that catalyzes the last step of melatonin synthesis is still unidentified in the house mouse (Mus musculus) despite the completion of the genome sequence. Here we report the identification of the mouse Hiomt gene, which was mapped to the pseudoautosomal region (PAR) of sex chromosomes. The gene was highly polymorphic, and nonsynonymous SNPs were found in melatonin-deficient strains. In C57BL/6 strain, there are two mutations, both of which markedly reduce protein expression. Mutability of the Hiomt likely due to a high recombination rate in the PAR could be the genomic basis for the high prevalence of melatonin deficiency. To understand the physiologic basis, we examined a wild-derived strain, MSM/Ms, which produced melatonin more under a short-day condition than a long-day condition, accompanied by increased Hiomt expression. We generated F2 intercrosses between MSM/Ms and C57BL/6 strains and N2 backcrosses to investigate the role of melatonin productivity on the physiology of mice. Although there was no apparent effect of melatonin productivity on the circadian behaviors, testis development was significantly promoted in melatonin-deficient mice. Exogenous melatonin also had the antigonadal action in mice of a melatonin-deficient strain. These findings suggest a favorable impact of melatonin deficiency due to Hiomt mutations on domestic mice in breeding colonies.


Journal of Biological Chemistry | 2007

The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development.

Akiko Hayashi; Takaoki Kasahara; Kazuya Iwamoto; Mizuho Ishiwata; Mizue Kametani; Chihiro Kakiuchi; Teiichi Furuichi; Tadafumi Kato

Accumulation of unfolded proteins in the endoplasmic reticulum initiates intracellular signaling termed the unfolded protein response (UPR). Although Xbp1 serves as a pivotal transcription factor for the UPR, the physiological role of UPR signaling and Xbp1 in the central nervous system remains to be elucidated. Here, we show that Xbp1 mRNA was highly expressed during neurodevelopment and activated Xbp1 protein was distributed throughout developing neurons, including neurites. The isolated neurite culture system and time-lapse imaging demonstrated that Xbp1 was activated in neurites in response to brain-derived neurotrophic factor (BDNF), followed by subsequent translocation of the active Xbp1 into the nucleus. BDNF-dependent neurite outgrowth was significantly attenuated in Xbp1-/- neurons. These findings suggest that BDNF initiates UPR signaling in neurites and that Xbp1, which is activated as part of the UPR, conveys the local information from neurites to the nucleus, contributing the neurite outgrowth.


Genes to Cells | 2001

Chicken pineal clock genes: implication of BMAL2 as a bidirectional regulator in circadian clock oscillation.

Toshiyuki Okano; Kazuyuki Yamamoto; Keiko Okano; Tsuyoshi Hirota; Takaoki Kasahara; Momoko Sasaki; Yoko Takanaka; Yoshitaka Fukada

Background In a transcription/translation‐based autoregulatory feedback loop of vertebrate circadian clock systems, a BMAL1‐CLOCK heterodimer is a positive regulator for the transcription of the negative element gene Per. The chicken pineal gland represents a photosensitive clock tissue, but the pineal clock genes constituting the oscillator loop have been less well characterized.


Neuroscience & Biobehavioral Reviews | 2007

Animal models of bipolar disorder.

Tadafumi Kato; Mie Kubota; Takaoki Kasahara

Animal models of human diseases should meet three sets of criteria: construct validity, face validity, and predictive validity. To date, several putative animal models of bipolar disorder have been reported. They are classified into various categories: pharmacological models, nutritional models, environmental models, and genetic models. None of them, however, totally fulfills the three validity criteria, and thus may not be useful for drug development. Mounting evidence suggests that mitochondrial dysfunction has a role in bipolar disorder. To test whether accumulation of mtDNA deletions in the brain can cause bipolar disorder, we generated transgenic mice with neuron-specific expression of mutant Polg (D181A). These mice showed altered diurnal activity rhythm and periodic activity change associated with the estrous cycle. These phenotypes were worsened by administration of a tricyclic antidepressant, but improved after lithium treatment. This mouse model of bipolar disorder potentially fulfills the three validity criteria, and therefore might be used for future drug development studies.


The International Journal of Neuropsychopharmacology | 2009

Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder

Akiko Hayashi; Takaoki Kasahara; Mizue Kametani; Tomoko Toyota; Takeo Yoshikawa; Tadafumi Kato

Impaired endoplasmic reticulum (ER) stress response has been suggested as a possible pathophysiological mechanism of bipolar disorder (BD). The expression of ER stress-related genes, spliced form or unspliced form of XBP1, GRP78 (HSPA5), GRP94 (HSP90B1), CHOP (DDIT3), and calreticulin (CALR), were examined in lymphoblastoid cells derived from 59 patients with BD and 59 age- and sex-matched control subjects. Basal mRNA levels and induction by 4 h or 12 h of treatment with two ER stressors, thapsigargin or tunicamycin, were examined using real-time quantitative reverse transcription-polymerase chain reaction. Induction of the spliced form of XBP1 as well as total XBP1 by thapsigargin was significantly attenuated in patients with BD. Induction of GRP94 by thapsigargin was also decreased in the BD group. A haplotype of GRP94, protective against BD, exhibited significantly higher GRP94 expression upon ER stress. This report confirms and extends earlier observations of impaired ER stress response in larger samples of lymphoblastoid cell lines derived from BD patients. Altered ER stress response may play a role in the pathophysiology of BD by altering neural development and plasticity.


Neuroscience Research | 2008

Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder

Tadafumi Kato; Mizuho Ishiwata; Kazuyuki Yamada; Takaoki Kasahara; Chihiro Kakiuchi; Kazuya Iwamoto; Koki Kawamura; Hisamitsu Ishihara; Yoshitomo Oka

Wolfram disease is a rare genetic disorder frequently accompanying depression and psychosis. Non-symptomatic mutation carriers also have higher rates of depression and suicide. Because WfS1, the causative gene of Wolfram disease, is located at 4p16, a linkage locus for bipolar disorder, mutations of WfS1 were suggested to be involved in the pathophysiology of bipolar disorder. In this study, we performed behavioral and gene expression analyses of Wfs1 knockout mice to assess the validity as an animal model of mood disorder. In addition, the distribution of Wfs1 protein was examined in mouse brain. Wfs1 knockout mice did not show abnormalities in circadian rhythm and periodic fluctuation of wheel-running activity. Behavioral analysis showed that Wfs1 knockout mice had retardation in emotionally triggered behavior, decreased social interaction, and altered behavioral despair depending on experimental conditions. Wfs1-like immunoreactivity in mouse brain showed a similar distribution pattern to that in rats, including several nuclei potentially relevant to the symptoms of mood disorders. Gene expression analysis showed down-regulation of Cdc42ep5 and Rnd1, both of which are related to Rho GTPase, which plays a role in dendrite development. These findings may be relevant to the mood disorder observed in patients with Wolfram disease.


The Journal of Neuroscience | 2006

Abnormal Ca2+ Dynamics in Transgenic Mice with Neuron-Specific Mitochondrial DNA Defects

Mie Kubota; Takaoki Kasahara; Takeshi Nakamura; Mizuho Ishiwata; Taeko Miyauchi; Tadafumi Kato

Maintenance of mitochondrial DNA (mtDNA) depends on nuclear-encoded proteins such as mtDNA polymerase (POLG), whose mutations are involved in the diseases caused by mtDNA defects including mutation and deletion. The defects in mtDNA and in intracellular Ca2+ ([Ca2+]i) homeostasis have been reported in bipolar disorder (BD). To understand the relevance of the mtDNA defects to BD, we studied transgenic (Tg) mice in which mutant POLG (mutPOLG) was expressed specifically in neurons. mtDNA defects were accumulated in the brains of mutPOLG Tg mice in an age-dependent manner and the mutant mice showed BD-like behavior. However, the molecular and cellular basis for the abnormalities has not been clarified. In this study, we investigated Ca2+ regulation by isolated mitochondria and [Ca2+]i dynamics in the neurons of mutPOLG Tg mice. Mitochondria from the mutant mice sequestered Ca2+ more rapidly, whereas Ca2+ retention capacity and membrane potential, a driving force of Ca2+ uptake, of mitochondria were unaffected. To elucidate the molecular mechanism of the altered Ca2+ uptake, we performed DNA microarray analysis and found that the expression of cyclophilin D (CyP-D), a component of the permeability transition pore, was downregulated in the brains of mutPOLG Tg mice. Cyclosporin A, an inhibitor of CyP-D, mimicked the enhanced Ca2+ uptake in mutant mice. Furthermore, G-protein-coupled receptor-mediated [Ca2+]i increase was attenuated in hippocampal neurons of the mutant mice. These findings suggest that mtDNA defects lead to enhancement of Ca2+ uptake rate via CyP-D downregulation and alter [Ca2+]i dynamics, which may be involved in the pathogenesis of BD.

Collaboration


Dive into the Takaoki Kasahara's collaboration.

Top Co-Authors

Avatar

Tadafumi Kato

RIKEN Brain Science Institute

View shared research outputs
Top Co-Authors

Avatar

Mizuho Ishiwata

RIKEN Brain Science Institute

View shared research outputs
Top Co-Authors

Avatar

Mie Kubota

RIKEN Brain Science Institute

View shared research outputs
Top Co-Authors

Avatar

Taeko Miyauchi

RIKEN Brain Science Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chihiro Kakiuchi

RIKEN Brain Science Institute

View shared research outputs
Top Co-Authors

Avatar

Mizue Kametani

RIKEN Brain Science Institute

View shared research outputs
Top Co-Authors

Avatar

Akiko Hayashi

Tokyo University of Pharmacy and Life Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge